论文部分内容阅读
糖尿病是由多种病因引起的以慢性高血糖为特征的代谢紊乱,二甲双胍是2型糖尿病治疗的一线药物,门冬胰岛素30多被用于进行外源性胰岛素补充。本文主要探讨对于老年初诊2型糖尿病患者应用门冬胰岛素30联合二甲双胍治疗的临床效果,分析如下。1资料与方法1.1临床资料选取初诊2型糖尿病患者120例,其中男61例,女59例,年龄60~76岁,平均(68.2±4.1)岁。入选患者符合WHOT2DM诊断标准[1],均
Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia caused by a variety of causes. Metformin is a first-line drug for the treatment of type 2 diabetes. More than 30 insulin asparts are used for exogenous insulin replenishment. This article mainly discusses the application of aspart 30 insulin combined with metformin in elderly patients with newly diagnosed type 2 diabetes, the clinical effect is analyzed as follows. 1 Materials and Methods 1.1 Clinical data 120 cases of newly diagnosed type 2 diabetes patients, including 61 males and 59 females, aged 60 to 76 years, mean (68.2 ± 4.1) years. Selected patients meet WHOT2DM diagnostic criteria [1], both